Showing results (2851-2860 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|February 24, 2017
FOXO3, estrogen receptor alpha, and androgen receptor impact tumor growth rate and infiltration of dendritic cell subsets differentially between male and female miceMatthew G Thompson, Daniel S Peiffer, Michelle Larson, et al.Cancer Immunology, Immunotherapy : CII|February 28, 2017
Interleukin 21 inhibits cancer-mediated FOXP3 induction in naïve human CD4 T cellsVinodh Kannappan, Kate Butcher, Malgorzata Trela, et al.Cancer Immunology, Immunotherapy : CII|March 1, 2017
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor siteTakayuki Ohkuri, Akemi Kosaka, Kei Ishibashi, et al.Cancer Immunology, Immunotherapy : CII|April 30, 2014
Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APC(Min/+) micePaulina Akeus, Veronica Langenes, Astrid von Mentzer, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Synergistic induction of lymphokine (IL-2)-activated killer activity by IL-2 and the polysaccharide lentinan, and therapy of spontaneous pulmonary metastasesK Yamasaki, S Sone, T Yamashita, et al.Cancer Immunology, Immunotherapy : CII|February 20, 2017
Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunitiesMarcin Kortylewski, Dayson MoreiraCancer Immunology, Immunotherapy : CII|March 12, 2017
Phenotype and function of tumor-associated neutrophils and their subsets in early-stage human lung cancerEvgeniy B EruslanovCancer Immunology, Immunotherapy : CII|February 19, 2017
PD-1 and PD-L1 antibodies in cancer: current status and future directionsArjun Vasant Balar, Jeffrey S WeberCancer Immunology, Immunotherapy : CII|January 1, 1987
Depressed natural cytotoxicity but normal natural killer cytotoxic factor (NKCF) production by mononuclear cells derived from patients with hepatocellular carcinomaR H Brookes, M C Kew, A R RabsonCancer Immunology, Immunotherapy : CII|January 1, 1988
Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparationM Katano, H Yamamoto, T Mizoguchi, et al.Pageof 652